<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Prassas, E.</style></author><author><style face="normal" font="default" size="100%">A Petrou</style></author><author><style face="normal" font="default" size="100%">M Kontos</style></author><author><style face="normal" font="default" size="100%">Rizos, D.</style></author><author><style face="normal" font="default" size="100%">K Neofytou</style></author><author><style face="normal" font="default" size="100%">Pikoulis, E</style></author><author><style face="normal" font="default" size="100%">Diamantis, T</style></author><author><style face="normal" font="default" size="100%">Felekouras, E</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Radiofrequency ablation assisted resection for hepatocellular carcinoma: Morbidity, mortality and long term survival</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of B.U.ON.</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Hepatocellular carcinoma</style></keyword><keyword><style  face="normal" font="default" size="100%">Liver resection</style></keyword><keyword><style  face="normal" font="default" size="100%">Radiofrequency ablation</style></keyword><keyword><style  face="normal" font="default" size="100%">Survival</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014///</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">19</style></volume><pages><style face="normal" font="default" size="100%">256 - 262</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Purpose; Hepatic resection is the mainstay of the curative treatment of primary hepatic tumors, with constantly improving short and long term results. Radiofrequency ablation (RFA)-assisted liver resection is a relatively new method of transection of the liver parenchyma with favorable intra- and perioperative results. The aim of this study was to investigate the oncological efficacy (long term overall survival/OS and disease free survival/DFS) and to confirm the favorable short term morbidity and mortality. Methods: Between May 2004 and January 2007, 28 patients underwent 32 resections with removal of 50 hepatocellular carcinoma (HCC) lesions. The technique of parenchymal transection has been described previously as RFA-assisted liver resection. Results: Thirty-day morbidity and mortality were 42.8 and 0%, respectively. Blood transfusion was necessary for 28.5% of the patients. The median hospital stay was 16.5 days (range 5-34). The 1- and 3-year OS were 92.9 and 65.7%, respectively. The 1- and 3-year DFS were 62.3 and 54.6% respectively. No patient developed metastatic disease or local recurrence at the margin site. Twelve patients (42.9%) developed in-the-liver recurrence away from the resection area. Conclusion: RFA-assisted liver resection is a safe and oncologically efficacious method for the surgical treatment of HCC with results comparable to other surgical techniques.</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue></record></records></xml>